The researchers examined patients with degenerative disc disease at a single level who either underwent ACDF or disc replacement with ProDisc-C in the investigational device exemption study. The baseline health state utility value was 0.54 in both the ACDF and CDR groups.
The researchers found HSU value changes in both groups at 24 months; CDR had an HSU value of 0.72 while ACDF had an HSU of 0.71. “Both treatments were found to have significant impact on the HSU values. These values are integral to the future of [cost-effective analysis] of ACDF and CDR,” concluded the study authors.
More Articles on Spine Surgery:
Dr. Gunnar Andersson Becomes 2014 ISASS President
Looking Ahead to ICD-10: Are Spine Surgeons Prepared?
5 Findings on Inconsistency in Spine Literature: Abstract vs. Manuscript
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
